Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014

6th Annual Drug Development Congress 2014

02 Jun 2014 - 03 Jun 2014 - Geneva, Switzerland

Bookmark and Share

This congress offers an executive platform for networking and discussion. Delegates will benefit from the opportunity to: Hear from and meet with the key innovators in predictive science and translational medicine. Previous attendees include: Executive Director, Safety Assessment, Novartis; Vice President, Translational Patient Safety, AstraZeneca; Head Clinical Pharmacokinetics, Bayer HealthCare Discover collaborative solutions to drug development challenges. This summit brings together a host of experts to compare methods for maximising the role of PKPD in early decision-making, implementing exploratory toxicology throughout the pipeline and applying predictive science to multi-target therapies. Discuss the latest innovations in drug development, including stem cell technology for predictive modelling, resistance biomarker studies and toxicogenomic applications for translational science. Enjoy unparalleled networking opportunities. The two-day congress format combines dedicated networking breaks, pre-organised 1-2-1 meetings and our popular drinks reception. The exhibition hall and poster presentation spaces offer a relaxed and professional environment for discussion. The congress is co-located with the 15th Annual Drug Discovery Summit, a senior level event looking into medicinal chemistry, research strategy, discovery technology and drug design. For more information on attendance, prices or to download the agenda please contact Danielle Dalby on

Further information
Scientific News
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Potential Target for Treatment of Autism
Grant of $2.4 million will support further research.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos